Variation
in the pharmacologic action of many drugs correlates more closely with the serum
concentration of active drug or metabolite or the free fraction in serum than
with the dose. Monitoring of serum levels is useful in a variety of situations:
- When
there is wide pharmacokinetic variation among individuals.
- When
zero order kinetics apply; e.g., phenytoin, where the drug is eliminated at
a constant rate rather than at a rate proportional to the amount of remaining
drug.
- When
the therapeutic index of a drug is low; i.e., when there is a small difference
between the toxic and effective concentrations.
- When
signs of toxicity are difficult to recognize clinically.
- When
physiologic factors are present which may affect drug pharmacokinetics; e.g.,
age, nutritional state, etc.
- When
intercurrent illness is present that may affect drug pharmacokinetics; e.g.,
kidney damage or liver damage.
- When
the usual dose does not give expected results.
- When
noncompliance is suspected.
- When
surreptitious use is suspected.
- When
drug interactions are suspected.
Time
of Sampling
Steady state
drug concentrations are most generally useful when the drug has reached equilibrium
and the amount of the drug systematically available is equal to the amount being
eliminated. Trough levels, drawn immediately before the next dose, are
used for constant maintenance in the therapeutic range. Peak levels, usually
drawn one to two hours after the dose, may be useful to detect possible toxic
levels.
Therapeutic
drug levels are also affected by age, disease states, metabolism, and the presence
of other drugs. Therapeutic decisions should never be based solely on
drug concentration in serum.
Ordering Tests for Therapeutic Drug Monitoring: As serum levels are affected
by dose, time of dose, and whether steady state has been achieved (after four
to five half-lives), requests for therapeutic drug levels must be accompanied
by draw time. Dose, dosing schedule and draw time are necessary for correct interpretation
of test results.
|